Literature DB >> 19683083

Hepcidin assay in serum by SELDI-TOF-MS and other approaches.

Annalisa Castagna1, Natascia Campostrini, Federica Zaninotto, Domenico Girelli.   

Abstract

Hepcidin, a liver peptide hormone, is the central regulator of iron homeostasis. Hepcidin synthesis is modulated by iron stores, so that iron repletion increases its levels to prevent pathological overload, while iron deficiency strongly inhibits hepcidin to allow an increase in iron absorption from duodenal cells. The emerging pivotal role of hepcidin in iron homeostasis, along with its important links with basic pathways like inflammation, makes the availability of an accurate hepcidin assay as a potentially powerful investigative tool to improve our understanding as well as our diagnostic/prognostic capabilities in many human diseases. There has been a great interest worldwide in developing a reliable and widely applicable assay of the hormone in biological fluids. Being optimal for low-molecular-weight biomarkers, SELDI-TOF-MS has emerged as a valid tool for hepcidin assay. Here we review recent results obtained with this technique, as well as with other Mass Spectrometry-based and immunological methods. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683083     DOI: 10.1016/j.jprot.2009.08.003

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  14 in total

1.  Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.

Authors:  Joshua Zaritsky; Brian Young; Barbara Gales; He-Jing Wang; Anjay Rastogi; Mark Westerman; Elizabeta Nemeth; Tomas Ganz; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

2.  Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.

Authors:  Maura Poli; Michela Asperti; Annamaria Naggi; Natascia Campostrini; Domenico Girelli; Michela Corbella; Marina Benzi; Celine Besson-Fournier; Helene Coppin; Federica Maccarinelli; Dario Finazzi; Paolo Arosio
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

3.  A novel monoclonal antibody immunoassay for the detection of human serum hepcidin.

Authors:  Peggy Schwarz; Pavel Strnad; Guido von Figura; Alfred Janetzko; Pierre Krayenbühl; Guido Adler; Hasan Kulaksiz
Journal:  J Gastroenterol       Date:  2010-12-07       Impact factor: 7.527

4.  Hepcidin in beta-thalassemia.

Authors:  Elizabeta Nemeth
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

5.  A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.

Authors:  Domenico Girelli; Paola Trombini; Fabiana Busti; Natascia Campostrini; Marco Sandri; Sara Pelucchi; Mark Westerman; Tomas Ganz; Elizabeta Nemeth; Alberto Piperno; Clara Camaschella
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

6.  Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.

Authors:  Nicola Martinelli; Michela Traglia; Natascia Campostrini; Ginevra Biino; Michela Corbella; Cinzia Sala; Fabiana Busti; Corrado Masciullo; Daniele Manna; Sara Previtali; Annalisa Castagna; Giorgio Pistis; Oliviero Olivieri; Daniela Toniolo; Clara Camaschella; Domenico Girelli
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

7.  Hepcidin levels and their determinants in different types of myelodysplastic syndromes.

Authors:  Valeria Santini; Domenico Girelli; Alessandro Sanna; Nicola Martinelli; Lorena Duca; Natascia Campostrini; Agostino Cortelezzi; Michela Corbella; Alberto Bosi; Gianluigi Reda; Oliviero Olivieri; Maria Domenica Cappellini
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

8.  Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25.

Authors:  Lucia Cenci; Erika Andreetto; Ambra Vestri; Michele Bovi; Mario Barozzi; Erica Iacob; Mirko Busato; Annalisa Castagna; Domenico Girelli; Alessandra Maria Bossi
Journal:  J Nanobiotechnology       Date:  2015-08-27       Impact factor: 10.435

9.  Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.

Authors:  Elizabeta Nemeth
Journal:  Adv Hematol       Date:  2009-12-24

10.  Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study.

Authors:  Natascia Campostrini; Michela Traglia; Nicola Martinelli; Michela Corbella; Massimiliano Cocca; Daniele Manna; Annalisa Castagna; Corrado Masciullo; Laura Silvestri; Oliviero Olivieri; Daniela Toniolo; Clara Camaschella; Domenico Girelli
Journal:  J Proteomics       Date:  2012-08-21       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.